Concepedia

Rachel Cant

RC

4

Publications

446

Citations

4

H-Index

2012

Active since

Affiliations

Cellular Therapeutics (United Kingdom)(Current)

Rachel Cant is an author at Cellular Therapeutics (United Kingdom) specializing in autoimmunity, inflammation, and immunology.

Top concepts

Publications per year

2012–2017

4

Publications

4

Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-β (TGF-β) Signaling Promoting SMAD3 Activation and Fibrosis via Gremlin Protein

Steven O’Reilly, Marzena Ciechomska, Rachel Cant et al. · Journal of Biological Chemistry · 2014 · 235 citations · Full text

Interleukin-6, its role in fibrosing conditions

Steven O’Reilly, Marzena Ciechomska, Rachel Cant et al. · Cytokine & Growth Factor Reviews · 2012 · 81 citations

, , +7

Serum amyloid A induces interleukin‐6 in dermal fibroblasts via <scp>T</scp>oll‐like receptor 2, interleukin‐1 receptor‐associated kinase 4 and nuclear factor‐<i>κ</i>B

Steven O’Reilly, Rachel Cant, Marzena Ciechomska et al. · Immunology · 2014 · 67 citations · Full text

, , +26

Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like Receptors

Rachel Cant, Angus Dalgleish, Rachel Allen · Frontiers in Immunology · 2017 · 63 citations · Full text

Rows per page

1–4 of 4